Company news

Sansure Biotech Inc. Class A (SSE:688289) news

Sansure Biotech Inc. Class A news releases on 6ix. Latest, Sep 29, 2026: "Sansure Biotech Inc."Announcement on Approval of Registration for Medium-term Notes

Sansure Biotech Inc. Class A (SSE:688289) news

Press releases & updates

"Sansure Biotech Inc."Announcement on Approval of Registration for Medium-term Notes

"Sansure Biotech Inc."Announcement on Results of Completion of Execution of Certain Shares Held by the Former Shareholder Holding More Than 5% of the Shares

"Sansure Biotech Inc."Announcement on Resignation of the Board Secretary and Designation of the Chairman to Act as the Board Secretary

"Sansure Biotech Inc."Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026

"Sansure Biotech Inc."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026

"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products

"Sansure Biotech Inc."Announcement on Use of Certain Temporarily Idle Raised Funds for Cash Management

"Sansure Biotech Inc."Indicative Announcement on the Proposed Judicial Enforcement of Certain Shares Held by a Former Shareholder Holding More Than 5% of the Shares

"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining EU CE Certification for Relevant Products

"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Relevant Products

"Sansure Biotech Inc."Announcement on Implementation Results of Share Repurchase

"Sansure Biotech Inc."Announcement on Voluntary Disclosure of the Obtaining of Medical Device Registration Certificates for Relevant Products

"Sansure Biotech Inc."Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

"Sansure Biotech Inc."Announcement on Progress in Repurchasing Shares through Call Auction

Announcement on Initially Repurchasing Shares through Call Auction

Announcement on the Implementation Results of the Judicial Compulsory Execution of Partial Shares of a Shareholder Holding Over 5% Shares

Announcement on Changing the Purpose of and Canceling Partial Repurchased Shares and Reducing Registered Capital

Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 5% Scale

Indicative Announcement on the Implementation Results of the Judicial Compulsory Execution of Partial Shares of a Shareholder Holding Over 5% Shares and the Proposed Further Judicial Compulsory Execution

Announcement on Implementation of Dividend Distribution for 2025

Announcement on Reply to the Supervision and Inquiry Letter Regarding Information Disclosure of the 2025 Annual Report

Announcement on Joint Capital Increase in Hunan Sansure SpeedBio Biotechnology Co., Ltd. with a Related Party

Announcement on Vesting Results in the 2nd Vesting Period of 2023 Restricted Stock Incentive Plan

Announcement on Resolutions of the 2025 Annual General Meeting

Report for Q1 2026

Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Relevant Products

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

Notice on Convening the 2nd Extraordinary General Meeting in 2026

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Announcement on Joint Investment with a Related Party in Huasi Wuwei Technology (Shenzhen) Co., Ltd.

Announcement on Joint Investment with a Related Party in Beijing Zheyuan Technology Co., Ltd.

Announcement on Preliminary Earnings Estimate for 2025

Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary

Announcement on Progress in Establishing a Fund through Co-investment with Professional Institutions and Related Party Transaction

Announcement on Vesting Results for the 1st Vesting Period of the Initial Granted Part under the 2023 Phase II Restricted Stock Incentive Plan

Announcement on Voluntary Disclosure in the Related Product Obtaining the EU CE Certification

Indicative Announcement on Proposed Judicial Freezing and Enforcement of Some Shares Held by Shareholder with Over 5% Shares

Announcement on Resolutions of the 5th Extraordinary Meeting of the 3rd Board of Directors in 2025

Announcement on Convening the Q3 2025 Performance Briefing

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025

Announcement on Voluntary Disclosure in the Related Product Obtaining the Medical Device Registration Certificate and the EU CE Certification

Announcement on Resignation of Core Technical Personnel

Announcement on Establishing a Fund through Co-investment with Professional Institutions and Related Party Transaction

Announcement on Implementation of Semi-annual Dividend Distribution for 2025

Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Hunan Jurisdiction and Semi-annual Performance Briefing

Full Text of 2025 Semi-annual Report

Announcement on Attending the Interim Collective Performance Briefing of Listed Companies in Hunan Province on SSE STAR Market 2025

Announcement on Completion of Board of Directors Re-election and Appointment of Senior Management Member & Securities Affairs Representative

Self-Inspection Report on the Trading of Company's Stock by Information Insiders in 2025 Restricted Stock Incentive Plan

Inspection Opinions and Publicity Description of the Remuneration and Appraisal Committee of the Board of Directors on the List of Incentive Objects for the 2025 Restricted Stock Incentive Plan